CIT's Mark Davis to Lecture on "Fighting Cancer with Nanoparticle Medicines," Friday, Oct. 14
Mark Davis, Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology, will deliver a lecture titled "Fighting Cancer with Nanoparticle Medicines" Friday, Oct. 14, at 3 p.m. in Jacobs Believed In Me Auditorium, Featheringill Hall. A reception in Adams Atrium follows the lecture.
Davis is a founding editor of CaTTech and has served as associate editor of Chemistry of Materials and the AIChE Journal. He is a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope.
Davis was elected to the National Academy of Engineering in 1997 and the National Academy of Sciences in 2006. He is the first engineer to win the National Science Foundation's Alan T. Waterman Award. He is the founder of Calando Pharmaceuticals Inc., a company that created the first RNAi therapeutic to reach the clinic for treating cancer.
The lecture is the first of four scheduled to mark the School of Engineering’s 125th anniversary in 2011-2012. The school's annual distinguished lecture — The John R. and Donna S. Hall Engineering Lecture — has been expanded into a special series bringing four notable engineering leaders to campus, one each in October, November, January and March.